Peer-reviewedCC BYFrontiers in nutrition
Associations of metabolic dysfunction-associated steatotic liver disease and significant fibrosis phenotypes with glomerular hyperfiltration defined by indexed eGFR
- 1The First Clinical Medical College, Lanzhou University , ,
- 2Department of Gastroenterology, The First Hospital of Lanzhou University , ,
Related
- Factors associated with significant liver fibrosis in patients with type 2 diabetes mellitus and metabolic dysfunction-associated steatotic liver disease: a single-center retrospective study
- Sepsis-associated endothelial dysfunction: clinical phenotypes, biomarkers, bedside evidence, and translational implications
- From COVID-19-Associated Acute Kidney Injury to Long-Term Kidney Dysfunction: Recovery Phenotypes, Risk Stratification, and Post-COVID Renal Surveillance
- Hepatic HIF2α Modulates Extra‐Hepatic Disease‐Associated Phenotypes During Metabolic Dysfunction‐Associated Steatotic Liver Disease
- Multiple Organ Dysfunction Trajectory Phenotypes After Severe Trauma Are Associated With Distinct Immune Profiles and Outcomes
BibTeX
@article{tian2026associations,
title = {{Associations of metabolic dysfunction-associated steatotic liver disease and significant fibrosis phenotypes with glomerular hyperfiltration defined by indexed eGFR}},
author = {Wen Tian and Jiameng Wang and Xueling Xu and Qiang Li and Ya Zheng and Hong Lu},
journal = {Frontiers in nutrition},
year = {2026},
month = oct,
url = {https://europepmc.org/article/PMC/PMC13661452},
note = {CC BY},
}
RIS
TY - JOUR
TI - Associations of metabolic dysfunction-associated steatotic liver disease and significant fibrosis phenotypes with glomerular hyperfiltration defined by indexed eGFR
AU - Wen Tian
AU - Jiameng Wang
AU - Xueling Xu
AU - Qiang Li
AU - Ya Zheng
AU - Hong Lu
PY - 2026
DA - 2026/10/16
JO - Frontiers in nutrition
UR - https://europepmc.org/article/PMC/PMC13661452
SN - 2296-861X
ER -